Report cover image

2026 Global: Bioreactors And Fermenters Market -Competitive Review (2032) report

Publisher PerryHope Partners
Published Dec 15, 2025
Length 32 Pages
SKU # PHP20693712

Description

The 2026 Global: Bioreactors And Fermenters Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.

Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).

The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bioreactors and fermenters market by geography and historical trend. The scope of the report extends to sizing of the bioreactors and fermenters market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.

The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?

The ten market players in this report and a brief synopsis of their participation in the market are:

The bioreactors and fermenters market features dominant players like Sartorius AG, Thermo Fisher Scientific, Merck KGaA, Eppendorf AG, and Cytiva (Danaher), which lead through innovative single-use and stainless-steel systems for biopharmaceutical production. Sartorius AG excels with Ambr and BIOSTAT bioreactors, enabling scalable cell culture and microbial fermentation for high-density processes, emphasizing flexibility and reduced contamination risks. Thermo Fisher Scientific dominates via HyPerforma single-use platforms up to 2,000 liters, supporting cGMP facilities and process development with automated analytics. Merck KGaA advances Mobius single-use technologies for process intensification, while Eppendorf AG offers BioBLU and BioFlo series for low-volume to pilot-scale applications. Cytiva, under Danaher, provides Xcellerex systems for flexible biomanufacturing, driving efficiency in biologics scale-up.

Additional leaders include Lonza Group, WuXi Biologics, PBS Biotech, and Applikon Biotechnology, addressing specialized needs in contract manufacturing and advanced therapies. Lonza integrates bioreactor tech with CDMO services for microbial and live biotherapeutics, expanding GMP capacity for global demand. WuXi Biologics deploys 200L to 5,000L disposable systems, prioritizing cost-effective, eco-friendly production in its network. PBS Biotech pioneers vertical-wheel single-use bioreactors for cell therapy, enhancing scalability and yields. Applikon Biotechnology supplies precision fermenters for R&D, complemented by Bionet and Ollital Technology for microbial applications. These firms capitalize on the market's shift to single-use tech, projected to grow from USD 25.9 billion in 2025 to USD 73.7 billion by 2035 at 10.9% CAGR.

Innovation from Solida Biotech, Shanghai Bailun, and ZETA GmbH further shapes the landscape, focusing on automation and customization for pharma compliance. Solida Biotech and Shanghai Bailun deliver high-quality stainless and hybrid systems for biologics, while ZETA engineers tailor-made solutions with advanced controls. Stainless steel holds the largest share currently, but single-use variants promise faster growth due to lower costs and sterility advantages. These ten majors—Sartorius, Thermo Fisher, Merck, Eppendorf, Cytiva, Lonza, WuXi, PBS, Applikon, and Solida—collectively equip over 1,500 global facilities, fueling biologics expansion amid 12-14% annual sales growth. Their strategies emphasize lifecycle management, troubleshooting, and tech upgrades to sustain market leadership.

Table of Contents

32 Pages
1.0 Scope of Report and Methodology
2.0 Market SWOT Analysis and Players
2.1 Market Definition
2.2 Market Segments
2.3 Market Strengths
2.4 Market Weaknesses
2.5 Market Threats
2.6 Market Opportunities
2.7 Major Players
3.0 Competitive Analysis
3.1 Market Player 1
3.2 Market Player 2
3.3 Market Player 3
3.4 Market Player 4
3.5 Market Player 5
3.6 Market Player 6
3.7 Market Player 7
3.8 Market Player 8
3.9 Market Player 9
3.10 Market Player 10
4.0 Comparative Business Strategies
4.1 Comparative Business Strategies of Player 1 and 2
4.2 Comparative Business Strategies of Player 1 and 3
4.3 Comparative Business Strategies of Player 1 and 4
4.4 Comparative Business Strategies of Player 2 and 3
4.5 Comparative Business Strategies of Player 2 and 4
4.6 Comparative Business Strategies of Player 3 and 4
5.0 Appendix

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.